The good takeaway from any new announcement was reinforced buy an email someone here sent to investor relations contact who replied by saying "under ASX rules, the company could not continue to state that expect in human trials to commence in Q4" if the company knew of any reason why they wouldn't. Covid impact I guess is excluded from this foresight, however with Government position being hospitals can continue clinical work and many other clinical trials being approved and cancer being life threatening regardless of current pandemic. I am still very bullish on this one.
IBX Price at posting:
9.9¢ Sentiment: Buy Disclosure: Held
